Treatment or prevention of complications of acute ischemic stroke

被引:8
|
作者
Kappelle L.J. [1 ]
van der Worp H.B. [1 ]
机构
[1] University Department of Neurology, University Medical Centre Utrecht, R. Magnus Inst. for Neurosciences, 3508 GA Utrecht
关键词
Ischemic Stroke; Stroke Patient; Deep Venous Thrombosis; Acute Stroke; Acute Ischemic Stroke;
D O I
10.1007/s11910-004-0009-5
中图分类号
学科分类号
摘要
Both neurologic and medical complications influence outcome after stroke. Space-occupying supratentorial infarcts can cause transtentorial or uncal herniation, which leads to death. Treatments aimed at reducing intracranial pressure in patients with such infarcts are of unproven value. Mass-producing cerebellar infarction may lead to brainstem compression and obstructive hydrocephalus. These lesions often are treated surgically. Although anticonvulsants are not indicated for prophylaxis, the occurrence of epileptic seizures mandates treatment to prevent recurrences. Depression is common in the acute stage of stroke, but is probably not more prevalent after stroke than after myocardial infarction. Although dysphagia is common, it usually is a transient problem. Patients with a decrease of consciousness or brainstem dysfunction usually need tube feeding for a certain period of time. Medical complications, such as fever, infections, hyperglycemia, cardiac disorders, pressure sores, and deep venous thrombosis, are associated with a poor prognosis and should be treated as early as possible. Measures to prevent these complications are part of general care. Hypertension is very common during the week after stroke and should be treated only in case of extremely high values or malignant hypertension. A multi-disciplinary approach in the stroke unit is necessary to prevent and manage complications in the acute phase of stroke. Copyright © 2004 by Current Science Inc.
引用
收藏
页码:36 / 41
页数:5
相关论文
共 50 条
  • [1] Complications of endovascular treatment for acute ischemic stroke: Prevention and management
    Balami, Joyce S.
    White, Philip M.
    McMeekin, Peter J.
    Ford, Gary A.
    Buchan, Alastair M.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 (04) : 348 - 361
  • [2] Treatment of hypertension in acute ischemic stroke
    Anunaya R. Jain
    M. Fernanda Bellolio
    Latha G. Stead
    Current Treatment Options in Neurology, 2009, 11 : 120 - 125
  • [3] Acute Secondary Prevention of Ischemic Stroke: Overlooked No Longer
    Bulwa, Zachary B.
    Mendelson, Scott J.
    Brorson, James R.
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [4] Neuroprotective agents for the treatment of acute ischemic stroke
    Bruce Ovbiagele
    Chelsea S. Kidwell
    Sidney Starkman
    Jeffrey L. Saver
    Current Neurology and Neuroscience Reports, 2003, 3 (1) : 9 - 20
  • [5] Acute Treatment of Ischemic Stroke
    Lyden, Stephanie
    Wold, Jana
    NEUROLOGIC CLINICS, 2022, 40 (01) : 17 - 32
  • [6] Treatment of Acute Ischemic Stroke
    Siket, Matthew S.
    EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2016, 34 (04) : 861 - +
  • [7] Statins in prevention and treatment of ischemic stroke
    Fonyakin A.V.
    Geraskina L.A.
    Human Physiology, 2016, 42 (8) : 858 - 864
  • [8] Outcomes and Treatment Complications of Intravenous Urokinase Thrombolysis in Acute Ischemic Stroke in China
    Zhang, Rongrong
    Wei, Hui
    Ren, Yu
    Wu, Yanping
    Luo, Yetao
    Zhang, Lei
    Huo, Yingchao
    Feng, Jinzhou
    Monnier, Philippe P. P.
    Qin, Xinyue
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [9] Early complications of ischemic stroke
    Bart van der Worp H.
    Dianne Raaijmakers T.W.M.
    Jaap Kappelle L.
    Current Treatment Options in Neurology, 2008, 10 (6) : 440 - 449
  • [10] Key Articles and Guidelines in the Acute Management and Secondary Prevention of Ischemic Stroke
    Baker, William L.
    Marrs, Joel C.
    Davis, Lindsay E.
    Nutescu, Edith A.
    Rowe, A. Shaun
    Ryan, Melody
    Splinter, Michele Y.
    Vardeny, Orly
    Fagan, Susan C.
    PHARMACOTHERAPY, 2013, 33 (06): : e115 - e142